BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26285451)

  • 1. [BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].
    Jerusalem G; Collignon J; Josse C; Schroeder H; Rorive A; Frères P; Lambert F; Koopmansch B; Poncin A; Bours V
    Rev Med Liege; 2015; 70(5-6):269-76. PubMed ID: 26285451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
    Andre F; Vicier C; Delaloge S
    Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
    Berrada N; Delaloge S; André F
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii30-5. PubMed ID: 20943632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive treatments show promise in breast cancer.
    Baker H
    Lancet Oncol; 2016 Aug; 17(8):e327. PubMed ID: 27425815
    [No Abstract]   [Full Text] [Related]  

  • 5. Is precision medicine ready for use in breast cancer?
    Pusztai L
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment guideline for advanced or recurrent breast cancer].
    Watanabe T; Katsumata N; Saijo N
    Nihon Rinsho; 2000 Apr; 58 Suppl():237-45. PubMed ID: 11026001
    [No Abstract]   [Full Text] [Related]  

  • 7. Management and Outcomes in Metaplastic Breast Cancer.
    Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
    Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant chemotherapy of early stage breast cancer].
    Boér K
    Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
    Stover DG; Wagle N
    Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing chemotherapy in triple-negative breast cancer: the role of platinum.
    Telli M
    Am Soc Clin Oncol Educ Book; 2014; ():e37-42. PubMed ID: 24857126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target therapy for metastatic breast cancer.
    Rachdi H; Mokrani A; Batti R; Ayadi M; Chraiet N; Mezlini A
    Tunis Med; 2018; 96(8-9):465-471. PubMed ID: 30430522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Diagnosis and Management of Breast Cancer.
    McDonald ES; Clark AS; Tchou J; Zhang P; Freedman GM
    J Nucl Med; 2016 Feb; 57 Suppl 1():9S-16S. PubMed ID: 26834110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer highlights.
    Kuter I
    Oncologist; 1999; 4(4):299-308. PubMed ID: 10476541
    [No Abstract]   [Full Text] [Related]  

  • 17. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
    Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
    Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of molecular tools for extended adjuvant endocrine therapy decisions in early breast cancer.
    Ribnikar D; Bedard PL
    Future Oncol; 2017 Dec; 13(30):2733-2736. PubMed ID: 29168649
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer].
    Semiglazov VF; Kanaev SV; Bugrova IL; Chagunava OL
    Vopr Onkol; 1998; 44(4):408-13. PubMed ID: 9807203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in breast cancer therapy.
    Snyder RD
    Intern Med J; 2004 May; 34(5):266-9. PubMed ID: 15151673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.